Skip to content
America's Blood Centers
  • About Us
    • About
    • Leadership
    • Committees
    • Partners
      • Stop the Bleed National Partnership
      • National Partnerships User Guide
    • ABC Strategic Plan
    • Foundation
    • Career Center
    • Membership Directory
    • Women’s Executive Leadership Community
    • Executive Fellows Program
    • Corporate Partner Council
    • ADRP
  • Advocacy
    • Advocacy Agenda
    • Priorities
      • Strengthening the Cyber Resilience of the Blood Community
      • Reducing Unnecessary Regulatory Burdens
      • Modernizing the Licensure Process
      • Exempt Blood Center LDTs from Diagnostic Regulation Reforms
      • Diversifying the Donor Base
      • Expanding the Use of Blood in Ambulances
      • Strengthening the Blood Supply
    • Act for Blood
    • State-Based Advocacy
      • Map of State Legislation
      • Legislation We’re Watching
    • Blood Advocacy Week
    • Letters and Comments
    • Grassroots Handbook
    • Action Center
  • Events
    • Advocacy Summit
    • ABC Annual Meeting
    • Rise & Lead Workshop
    • All Upcoming Events
    • 2025 Awards of Excellence
    • Sponsors
  • News
    • Press Releases
    • One Pagers and FAQs
    • All Latest News
    • For Media
  • Publications
    • ABC Newsletter
    • Blood Bulletin
    • U.S. Blood Donation Statistics and Public Messaging Guide
    • Vein to Vein: The Science of Blood Donation
    • Blood Centers Career Video
    • ABC Benchmark Surveys
    • The Value of Blood
    • Advertise
    • Grant Funding Guide πŸ”’
  • For Members
    • Collaborate πŸ”’
    • Recent Member Communications (MCNs) πŸ”’
    • Talking Points πŸ”’
    • Member Snapshot Survey Reports πŸ”’
    • ABC Newsletter Archives πŸ”’
    • Webinar Recordings πŸ”’
      • Advocacy Webinars πŸ”’
      • Donor Management Webinars πŸ”’
      • Human Resources Webinars πŸ”’
      • SMIT Journal Club Webinars πŸ”’
    • Resources
    • Get Involved
    • Directory
  • Resources
    • About Blood
    • Blood Safety
    • Promote Blood
    • Journey of Blood
    • Find a Blood Center
    • Current U.S. Blood Supply
    • DonatingBlood.org
  • HOSA Partners
  • Become an ABC Member
  • Member Login
America's Blood Centers
  • About Us
    • About
    • Leadership
    • Committees
    • Partners
      • Stop the Bleed National Partnership
      • National Partnerships User Guide
    • ABC Strategic Plan
    • Foundation
    • Career Center
    • Membership Directory
    • Women’s Executive Leadership Community
    • Executive Fellows Program
    • Corporate Partner Council
    • ADRP
  • Advocacy
    • Advocacy Agenda
    • Priorities
      • Strengthening the Cyber Resilience of the Blood Community
      • Reducing Unnecessary Regulatory Burdens
      • Modernizing the Licensure Process
      • Exempt Blood Center LDTs from Diagnostic Regulation Reforms
      • Diversifying the Donor Base
      • Expanding the Use of Blood in Ambulances
      • Strengthening the Blood Supply
    • Act for Blood
    • State-Based Advocacy
      • Map of State Legislation
      • Legislation We’re Watching
    • Blood Advocacy Week
    • Letters and Comments
    • Grassroots Handbook
    • Action Center
  • Events
    • Advocacy Summit
    • ABC Annual Meeting
    • Rise & Lead Workshop
    • All Upcoming Events
    • 2025 Awards of Excellence
    • Sponsors
  • News
    • Press Releases
    • One Pagers and FAQs
    • All Latest News
    • For Media
  • Publications
    • ABC Newsletter
    • Blood Bulletin
    • U.S. Blood Donation Statistics and Public Messaging Guide
    • Vein to Vein: The Science of Blood Donation
    • Blood Centers Career Video
    • ABC Benchmark Surveys
    • The Value of Blood
    • Advertise
    • Grant Funding Guide πŸ”’
  • For Members
    • Collaborate πŸ”’
    • Recent Member Communications (MCNs) πŸ”’
    • Talking Points πŸ”’
    • Member Snapshot Survey Reports πŸ”’
    • ABC Newsletter Archives πŸ”’
    • Webinar Recordings πŸ”’
      • Advocacy Webinars πŸ”’
      • Donor Management Webinars πŸ”’
      • Human Resources Webinars πŸ”’
      • SMIT Journal Club Webinars πŸ”’
    • Resources
    • Get Involved
    • Directory
  • Resources
    • About Blood
    • Blood Safety
    • Promote Blood
    • Journey of Blood
    • Find a Blood Center
    • Current U.S. Blood Supply
    • DonatingBlood.org
December 8, 2023

Laboratory Developed Tests Comments Submitted

By America's Blood Centers

America’s Blood Centers (ABC) responded to the U.S. Food and Drug Administration’s (FDA) proposed laboratory developed tests (LDTs) rule in comments submitted on December 4th. In the laboratory developed tests rule comments, ABC described the potential negative impact of the proposed LDTs rule on both public health and the U.S. blood supply, in addition to its ability to be overly burdensome and, β€œprohibit patient access to tests necessary to ensure blood compatibility.”

ABC’s laboratory developed tests rule comments to the agency recommended that either blood centers be exempt from the regulation or that FDA revises the proposed LDTs rule to maintain the flexibility of the agency to exercise enforcement discretion over all tests developed and used by blood centers. The LDTs rule comments outlined four specific areas of concern with the regulation including:

  • β€œLDTs developed by blood establishments are not associated with the type of safety concerns FDA is addressing with this rule;
  • many LDTs developed in a blood center’s lab are 1976-Type LDTs and/or are developed with a high level of standardization across institutions;
  • blood centers’ LDTs are comparable to Human Leukocyte Antigen (HLA) tests. FDA should apply general enforcement discretion to all HLA tests and blood center’s LDTs; [and]
  • the impact [of the LDT regulation] on patient access.”

The LDTs rule comments explained that, β€œblood centers’ LDTs are extremely safe and effective under the current framework and do not have a history of safety issues. Blood centers and hospitals are required to report adverse events to FDA. The safety record of these tests is well-documented in this reporting system, and a mechanism exists to resolve any safety issues that are potentially identified.” Additionally, ABC noted in the laboratory developed tests rule comments that, β€œFDA is proposing to continue to apply the current general enforcement discretion approach to β€˜1976-Type LDTs…[Since many] serological tests developed in a blood center’s immunohematology reference laboratory (IRL) are 1976-type LDTs, [FDA] should continue to apply its current general enforcement discretion to these tests. These tests use manual techniques and are performed by highly trained laboratory personnel under the oversight of a blood center medical director and use licensed reagents.” The laboratory developed tests rule comments also described how, β€œ[these] tests are validated and rigorously quality-controlled, are well-established, and follow standard, published references for immunohematology. These test kits are not sold to any entity and are only utilized by the blood center. The volume of production for these tests does not make them commercially viable for mass marketing. Therefore, these important tests would be unavailable for use if not performed under the current enforcement discretion.”

In the laboratory developed tests rule comments, ABC listed additional examples of necessary tests used by blood centers that would be impacted by the new enforcement approach proposed in the LDT regulation including:

  • ABO discrepancy resolution;
  • other tests using in-house donor cells;
  • tests using anti-sera created from donor plasma;
  • flow cytometric analysis; and
  • molecular testing.

In urging FDA to apply the same rationale and reasoning used for exempting HLA LDTs for transplantation from the proposed rule, the ABC LDTs rule comments stated that a similar approach should be applied to, β€œall LDTs in blood centers and to all HLA tests [since such] tests are generally developed, and the testing is generally performed in urgent, life-saving situations for the patient, where a physician must make a prompt decision about the transfusion based on medical judgment regarding their patient’s condition and the degree of mismatch between the donor and patient when performing a blood transfusion.”

ABC concluded the laboratory developed tests rule comments by explaining that, β€œ[u]nless blood centers’ LDTs are fully excluded from FDA’s enforcement approach applied to in vitro diagnostic products (IVDs), there will be significant patient harm due to delays in care and the lack of patient access to medically necessary tests due to the new regulatory burdens. [These] tests are generally developed, and the testing is generally performed in urgent, life-saving situations for the patient, where a physician must make a prompt decision about the transfusion based on medical judgment regarding their patient’s condition and the degree of mismatch between the donor and patient when performing a blood transfusion. If these tests are unavailable, physicians must still make a prompt decision about the transfusion, and they will have less information available to them to determine the safest course of action.” ABC also noted the potential of the proposed LDT regulation to, β€œexacerbate the impact of the existing laboratory workforce shortage without improving safety. Blood centers would need to hire additional specialized staff and provide training to staff on a new, complicated FDA regulatory scheme. This would come at a time when pathology and laboratory medicine are experiencing extreme workforce challenges. For example, the overall vacancy rate for blood bank immunohematology laboratory departments was 17.8 percent in 2022, with staff vacancy rates at 18.9 percent.” ABC will continue to provide updates regarding the proposed rule.

An archive of all letters and comments on America’s Blood Centers’ blood advocacy initiatives is available on the ABC website.

READ THE FULL COMMENTS.
Posted in Letters and Comments
Share this

Recent Posts

  • Summer’s Hidden Challenge: The Critical Need for Blood Donations
  • America’s Blood Centers Releases New Report Showing the Critical Role of Community Blood Centers in Expanding Prehospital Blood Programs
  • Join ABC in Washington, D.C. for Our First Annual Advocacy Summit
  • America’s Blood Centers Joins Blood and Cells Advocacy Roster’s (BCAR) Think-Tank Consortium
  • Community Blood Centers: Innovating for Life – A Monthly Spotlight on America’s Blood Centers Members

Categories

  • ABC Newsletter
  • Blood Bulletin
  • Letters and Comments
  • News
  • One-Pagers and FAQs
  • Press Releases

Contact

abc-60-logo

1717 K Street NW, Suite 900
Washington, DC 20006

Tel:Β 202-393-5725

Fax:Β 202-899-2621

Link to Instagram Account - Americas Blood Centers
  • About Us
    • About
    • Leadership
    • Committees
    • Partners
      • Stop the Bleed National Partnership
      • National Partnerships User Guide
    • ABC Strategic Plan
    • Foundation
    • Career Center
    • Membership Directory
    • Women’s Executive Leadership Community
    • Executive Fellows Program
    • Corporate Partner Council
    • ADRP
  • Advocacy
    • Advocacy Agenda
    • Priorities
      • Strengthening the Cyber Resilience of the Blood Community
      • Reducing Unnecessary Regulatory Burdens
      • Modernizing the Licensure Process
      • Exempt Blood Center LDTs from Diagnostic Regulation Reforms
      • Diversifying the Donor Base
      • Expanding the Use of Blood in Ambulances
      • Strengthening the Blood Supply
    • Act for Blood
    • State-Based Advocacy
      • Map of State Legislation
      • Legislation We’re Watching
    • Blood Advocacy Week
    • Letters and Comments
    • Grassroots Handbook
    • Action Center
  • Events
    • Advocacy Summit
    • ABC Annual Meeting
    • Rise & Lead Workshop
    • All Upcoming Events
    • 2025 Awards of Excellence
    • Sponsors
  • News
    • Press Releases
    • One Pagers and FAQs
    • All Latest News
    • For Media
  • Publications
    • ABC Newsletter
    • Blood Bulletin
    • U.S. Blood Donation Statistics and Public Messaging Guide
    • Vein to Vein: The Science of Blood Donation
    • Blood Centers Career Video
    • ABC Benchmark Surveys
    • The Value of Blood
    • Advertise
    • Grant Funding Guide πŸ”’
  • For Members
    • Collaborate πŸ”’
    • Recent Member Communications (MCNs) πŸ”’
    • Talking Points πŸ”’
    • Member Snapshot Survey Reports πŸ”’
    • ABC Newsletter Archives πŸ”’
    • Webinar Recordings πŸ”’
      • Advocacy Webinars πŸ”’
      • Donor Management Webinars πŸ”’
      • Human Resources Webinars πŸ”’
      • SMIT Journal Club Webinars πŸ”’
    • Resources
    • Get Involved
    • Directory
  • Resources
    • About Blood
    • Blood Safety
    • Promote Blood
    • Journey of Blood
    • Find a Blood Center
    • Current U.S. Blood Supply
    • DonatingBlood.org
  • Sitemap
  • Privacy Policy
  • Terms of Use
Become a Member
Member Login

Copyright Β© 2025Β Β© America's Blood Centers. All Rights Reserved.

Website by Yoko Co

Scroll To Top